bezafibrate has been researched along with Arteriosclerosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Kanno, T; Kobori, K; Kondo, A; Kotani, K; Maekawa, M; Manabe, M; Morita, H; Nakamura, H; Saito, K | 1 |
| Schonfeld, G | 1 |
| Etti, H; Kondor, P; Pirich, C; Sinzinger, H | 1 |
| Seed, M | 1 |
| Sinzinger, H | 1 |
| Mooney, A | 1 |
| Tada, N | 1 |
| Betteridge, DJ | 1 |
| Bommer, J; Feussner, G; Ziegler, R | 1 |
| Acacia, E; Jones, C; Kremer, P; Marowski, C | 1 |
| Kostner, GM | 1 |
| Caimi, G; Catania, A; Francavilla, G; Romano, A; Santonocito, G; Sarno, A | 1 |
| Bulgarelli, A; Cassader, M; Niort, G; Pagano, G | 1 |
| Cabrera, J; Campos, MM; Escobar Jiménez, F; Núñez, J; Orduña, R; Torres, E; Vílchez Joya, R | 1 |
| Eisenberg, S | 1 |
6 review(s) available for bezafibrate and Arteriosclerosis
| Article | Year |
|---|---|
The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
Topics: Arteriosclerosis; Bezafibrate; Blood Coagulation; Clofibric Acid; Coronary Disease; Fenofibrate; Fibric Acids; Gemfibrozil; Hemostasis; Humans; Hypolipidemic Agents; Lipoproteins; Risk Factors | 1994 |
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis | 1998 |
Treating patients with hypertriglyceridaemia saves lives: triglyceride revisited.
Topics: Arteriosclerosis; Bezafibrate; Clinical Trials as Topic; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Risk Factors; Triglycerides | 1999 |
[Overviews of fibrate].
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Humans; Hyperlipidemias; Hypolipidemic Agents; Randomized Controlled Trials as Topic; Triglycerides | 2001 |
Lipid-lowering trials in diabetes.
Topics: Arteriosclerosis; Bezafibrate; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male | 2001 |
The affection of lipoprotein-a by lipid lowering drugs.
Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Neomycin; Niacin; Nicotinic Acids; Stanozolol | 1988 |
5 trial(s) available for bezafibrate and Arteriosclerosis
| Article | Year |
|---|---|
Influence of fibrate treatment on malondialdehyde-modified LDL concentration.
Topics: Adult; Aging; Apolipoproteins B; Arteriosclerosis; Bezafibrate; Diabetes Complications; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Sex Characteristics | 2004 |
Atherogenic risk reduction in patients with dyslipidaemia. comparison between bezafibrate and lovastatin.
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Bezafibrate; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Prospective Studies; Risk Factors | 1995 |
Therapeutic effects of bezafibrate and gemfibrozil in hyperlipoproteinaemia type IIa and IIb.
Topics: Adult; Aged; Argentina; Arteriosclerosis; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Triglycerides | 1989 |
Blood rheology changes during bezafibrate treatment.
Topics: Aged; Arteriosclerosis; Bezafibrate; Blood Viscosity; Clinical Trials as Topic; Double-Blind Method; Fibrinogen; Hematocrit; Humans; Middle Aged; Random Allocation | 1988 |
Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.
Topics: Adult; Aged; Arteriosclerosis; Bezafibrate; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Platelet Aggregation; Random Allocation; Rheology | 1988 |
4 other study(ies) available for bezafibrate and Arteriosclerosis
| Article | Year |
|---|---|
Therapy and clinical trials.
Topics: Arteriosclerosis; Bezafibrate; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins | 1996 |
Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
Topics: Apolipoproteins E; Arteriosclerosis; Bezafibrate; Cholesterol; Female; Genetic Carrier Screening; Humans; Hyperlipoproteinemia Type III; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Lipoproteins; Middle Aged; Renal Dialysis; Risk Factors; Triglycerides | 1990 |
[Effects of bezafibrate in patients with combined hyperlipidemia].
Topics: Arteriosclerosis; Bezafibrate; Cholesterol; Diabetes Mellitus, Type 2; Humans; Hyperlipidemia, Familial Combined; Male; Triglycerides | 1986 |
Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy.
Topics: Arteriosclerosis; Bezafibrate; Carrier Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1985 |